Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-01-31

FDA Approved: BUPRENORPHINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical Industries' supplemental application for buprenorphine (generic). The buprenorphine product is used to treat opioid use disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

SUPPL AP for BUPRENORPHINE (BUPRENORPHINE)